FINAL PROGR AM - American Society of Gene & Cell Therapy
FINAL PROGR AM - American Society of Gene & Cell Therapy
FINAL PROGR AM - American Society of Gene & Cell Therapy
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
150<br />
8th Annual Meeting • June 1 - 5, 2005 • St. Louis<br />
EXHIBITOR DESCRIPTIONS<br />
DNAVEC Corporation<br />
Toranomon 40MT Bldg. 9F<br />
5-13-1 Toranomon, Minato-ku, Tokyo 105-0001<br />
JAPAN<br />
Phone: +81-3-5403-7061<br />
Fax: +81-3-5403-7062<br />
E-Mail: info@dnavec-corp.com<br />
www.dnavec.co.jp<br />
Booth Number: 605<br />
DNAVEC has its own proprietary technology, Sendai<br />
Virus Vector (SeV). SeV is a novel “cytoplasmic RNA<br />
vector”, which is genetoxicity free and expresses a foreign<br />
gene quite efficiently. SeV has a wide application <strong>of</strong> gene<br />
therapy and gene vaccine mainly at cardiovascular disease<br />
and oncology.<br />
Elsevier<br />
525 B Street, Suite 1900<br />
San Diego, CA 92101<br />
Phone: 619-231-6616<br />
Fax: 619-699-6320<br />
www.elsevier.com<br />
Booth Number: 409<br />
Come to the Elsevier booth to browse our books and<br />
journals. Become an active member and receive a 50%<br />
discount on one <strong>of</strong> our selected books.<br />
GE Healthcare<br />
(formally known as Amersham Biosciences Corp)<br />
800 Centennial Ave.<br />
P.O. Box 1327<br />
Piscataway, NJ 08855-1327<br />
Phone: 800-526-3593 or 732-457-8000<br />
Fax: 778-295-8102<br />
E-Mail: cs-us@ge.com<br />
www.gehealthcare.com<br />
Booth Number: 506<br />
GE Healthcare provides transformational medical<br />
technologies that are shaping a new age <strong>of</strong> patient care.<br />
GE Healthcare’s expertise in medical imaging and<br />
information technologies, medical diagnostics, patient<br />
monitoring systems, disease research, drug discovery and<br />
biopharmaceuticals is dedicated to detecting disease<br />
earlier and tailoring treatment for individual patients.<br />
GENEART North America<br />
28 Kirk Bradden Road East<br />
M8Y 2E6 Etobicoke, Ontario<br />
CANADA<br />
Phone: 252-975-3417<br />
Fax: 252-975-1366<br />
E-Mail: patricia.nick@geneart.com<br />
www.genart.com<br />
Booth Number: 406<br />
Based on the technological platform gene synthesis,<br />
GENEART <strong>of</strong>fers integrated system solutions for<br />
pharmaceutical and biotech industries for developing<br />
DNA and protein-based therapeutic agents and vaccines.<br />
The spectrum <strong>of</strong> performance ranges from rational gene<br />
design and synthesis over generation <strong>of</strong> combinatorial<br />
gene libraries to the production <strong>of</strong> plasmid DNA in any<br />
amount including GMP quality.<br />
Invitrogen Corporation<br />
1620 Faraday Avenue<br />
Carlsbad, CA 92008<br />
Phone: 760-603-7200<br />
www.invivogen.com<br />
Booth Number: 414-416<br />
Invitrogen provides products and services that support<br />
academic and government research institutions and<br />
pharmaceutical and biotech companies worldwide in<br />
their efforts to improve the human condition. Our life<br />
science technologies improve and accelerate all areas <strong>of</strong><br />
research, drug discovery, and commercial bioproduction.<br />
InvivoGen<br />
3950 Sorrento Valley Boulevard, Suite A<br />
San Diego, CA 92121<br />
Phone: 858-457-5873<br />
Fax: 858-457-5843<br />
E-Mail: info@invivogen.com<br />
www.invivogen.com<br />
Booth Number: 615<br />
InvivoGen provides the research community with highquality<br />
products designed to accelerate discoveries in<br />
gene therapy research. InvivoGen has become a leader in<br />
RNAi research with our psiRNA family <strong>of</strong> silencing<br />
vectors. We also <strong>of</strong>fer a large choice <strong>of</strong> therapeutic genes<br />
cloned into various mammalian expression vectors.